Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3390/PHARMACEUTICS13081204 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Gold nanoparticles (AuNPs) have been shown to be outstanding tools for drug delivery and biomedical applications, mainly owing to their colloidal stability, surface chemistry, and photothermal properties. The biocompatibility and stability of nanoparticles can be improved by capping the nanoparticles with endogenous proteins, such as albumin. Notably, protein coating of nanoparticles can interfere with and decrease their cell penetration. Therefore, in the present study, we functionalized albumin with the r(8) peptide (All-D, octaarginine) and used it for coating NIR-plasmonic anisotropic gold nanoparticles. Gold nanoprisms (AuNPrs) and gold nanorods (AuNRs) were coated with bovine serum albumin (BSA) previously functionalized using a cell penetrating peptide (CPP) with the r(8) sequence (BSA-r(8)). The effect of the coated and r(8)-functionalized AuNPs on HeLa cell viability was assessed by the MTS assay, showing a low effect on cell viability after BSA coating. Moreover, the internalization of the nanostructures into HeLa cells was assessed by confocal microscopy and transmission electron microscopy (TEM). As a result, both nanoconstructs showed an improved internalization level after being capped with BSA-r(8), in contrast to the BSA-functionalized control, suggesting the predominant role of CPP functionalization in cell internalization. Thus, our results validate both novel nanoconstructs as potential candidates to be coated by endogenous proteins and functionalized with a CPP to optimize cell internalization. In a further approach, coating AuNPs with CPP-functionalized BSA can broaden the possibilities for biomedical applications by combining their optical properties, biocompatibility, and cell-penetration abilities.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Bolanos, Karen | Mujer |
Universidad de Chile - Chile
Ctr Estudios Ejercicio Metab & Canc CEMC - Chile Adv Ctr Chron Dis ACCDiS - Chile Centro de Estudios en Ejercicio - Chile Advanced Center for Chronic Diseases (ACCDiS) - Chile |
| 2 | Sanchez-Navarro, Macarena | Mujer |
Barcelona Inst Sci & Technol - España
IRB Barcelona - Institute for Research in Biomedicine - España |
| 3 | Tapia-Arellano, Andreas | Hombre |
Universidad de Chile - Chile
Adv Ctr Chron Dis ACCDiS - Chile Advanced Center for Chronic Diseases (ACCDiS) - Chile |
| 4 | Giralt, Ernest | Hombre |
Barcelona Inst Sci & Technol - España
Univ Barcelona - España IRB Barcelona - Institute for Research in Biomedicine - España Universitat de Barcelona - España |
| 5 | KOGAN-BOCIAN, MARCELO JAVIER | Hombre |
Universidad de Chile - Chile
Adv Ctr Chron Dis ACCDiS - Chile Advanced Center for Chronic Diseases (ACCDiS) - Chile |
| 6 | Araya, Eyleen | - |
Adv Ctr Chron Dis ACCDiS - Chile
Universidad Nacional Andrés Bello - Chile Advanced Center for Chronic Diseases (ACCDiS) - Chile |
| Fuente |
|---|
| FONDECYT |
| FONDEQUIP |
| FONDAP |
| Ministerio de Economía y Competitividad |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| European Regional Development Fund |
| Generalitat de Catalunya |
| Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias |
| Advanced Center for Chronic Diseases |
| MINECO-FEDER |
| Severo Ochoa Award of Excellence from MINECO (Government of Spain) |
| ANID |
| ANID, Chile |
| Agradecimiento |
|---|
| K.B. acknowledges ANID, Chile, Doctoral fellowship 21180258 and Advanced Center for Chronic Diseases. A.T.-A. acknowledges PhD fellowship number 21151461 and 23190312. E.A. acknowledges Fondecyt 1190623. M.J.K. acknowledges FONDECYT 1211482, FONDAP 15130011 and FONDEQUIP EQM170111. M.S.-N. and E.G. acknowledge MINECO-FEDER (BIO 2016-75327-R) and the Generalitat de Catalunya (XRB and 2017SGR-998). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). |
| K.B. acknowledges ANID, Chile, Doctoral fellowship 21180258 and Advanced Center for Chronic Diseases. A.T.-A. acknowledges PhD fellowship number 21151461 and 23190312. E.A. acknowledges Fondecyt 1190623. M.J.K. acknowledges FONDECYT 1211482, FONDAP 15130011 and FONDEQUIP EQM170111. M.S.-N. and E.G. acknowledge MINECO-FEDER (BIO 2016-75327-R) and the Generalitat de Catalunya (XRB and 2017SGR-998). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). |
| K.B. acknowledges ANID, Chile, Doctoral fellowship 21180258 and Advanced Center for Chronic Diseases. A.T.-A. acknowledges PhD fellowship number 21151461 and 23190312. E.A. acknowledges Fondecyt 1190623. M.J.K. acknowledges FONDECYT 1211482, FONDAP 15130011 and FONDEQUIP EQM170111. M.S.-N. and E.G. acknowledge MINECO-FEDER (BIO 2016-75327-R) and the Generalitat de Catalunya (XRB and 2017SGR-998). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). |